Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials
Objective. Critical limb ischemia (CLI) is the most dangerous stage of peripheral artery disease (PAD). Many basic researches and clinical treatment had been focused on stem cell transplantation for CLI. This systematic review was performed to review evidence for safety and efficacy of autologous st...
Saved in:
Main Authors: | Baocheng Xie, Houlong Luo, Yusheng Zhang, Qinghui Wang, Chenhui Zhou, Daohua Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2018/7528464 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia
by: Punam P. Parikh, et al.
Published: (2017-01-01) -
Cell Therapy in Patients with Critical Limb Ischemia
by: Rita Compagna, et al.
Published: (2015-01-01) -
Our Treatment Strategy for Critical Limb Ischemia
by: Tetsuo Yamada, et al.
Published: (2013-01-01) -
Therapeutic Evidence of Human Mesenchymal Stem Cell Transplantation for Cerebral Palsy: A Meta-Analysis of Randomized Controlled Trials
by: Baocheng Xie, et al.
Published: (2020-01-01) -
Clinical Efficacy and Safety of Human Mesenchymal Stem Cell Therapy for Degenerative Disc Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Baocheng Xie, et al.
Published: (2021-01-01)